From its Phase 1 research at the ERS Annual Congress in Barcelona.

Gilead, which logged nearly $6 billion in AIDS-drugs sales this past year, donated the gel’s important ingredient, marketed in the U.S. As a tablet known as Viread, and granted a royalty-free permit to Conrad, a non-profit reproductive-health organization that programs to distribute the merchandise in Africa, the news headlines service writes. Bloomberg BusinessWeek lists tips in HIV/AIDS medication pricing background: As prices fell, demand elevated, yielding economies of level which have helped lower prices additional, says Michael Kazatchkine, executive director of the Global Fund to Combat HIV/AIDS, Malaria and Tuberculosis, this article notes.If the condition keeps spreading since it has been we estimate there could be thousands of cases by the end of the year in Liberia only, said Bryan Lewis, a computational epidemiologist with the Network Dynamics and Simulation Technology Laboratory at the Virginia Bioinformatics Institute. Lewis and his fellow researchers use a combined mix of models to predict outcomes of the epidemic. The agent-based versions are adaptive, evolving as more info is normally fed into them, to provide a precise forecast. Pharmaceutical intervention, which continues to be on the horizon, is proving much less effective in the models than supportive treatment and personal protection apparatus for healthcare workers. The work with Ebola is not an isolated event, stated Christopher Barrett, the executive director of the institute.